It is a pharma private limited company based in New Delhi, Delhi, India, established in 1996.
1996 | New Delhi, Delhi, India | ActiveDynor Pharmaceuticals Private Limited, a active private limited company, was established on 18 March 1996 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24231DL1996PTC077290. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Bharat Bhushan Tuteja (Managing Director), Manik Tuteja (Director). Past directors included Manik Tuteja, Navneet Kochar, Jatinder Kumar. It holds ₹1.20 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 10/38 Geeta Colony, New Delhi, Delhi, 110031.
U24231DL1996PTC077290
077290
18 March 1996
₹0.50 M
₹0.50 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Dynor Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bharat Bhushan Tuteja | Managing Director | 18 Mar 1996 | Current |
| Manik Tuteja | Director | 20 Oct 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2023 | Past |
| Pramod Abcsdd | Managing Director | 20 Jan 2008 | Past |
| Pramod Abcsdd | Director | 20 Oct 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dynor Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 16.44% decrease. The company also saw a substantial fall in profitability, with a 18.99% decrease in profit. The company's net worth moved up by a moderate rise of 4.74%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Dynor Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,200,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 May 2009 | State Bank Of India | ₹1.20 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Dynor Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Dynor Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dynor Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Dynor Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Dynor Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
The activity Manik Tuteja was appointed as a Director was appointed as a Director on 20 Oct 2022 & has been associated with this company since 3 years 1 month . was completed.
Progress on A charge with State Bank Of India amounted to Rs. 1.20 M with Charge ID 10159927 was registered on 06 May 2009. was documented.
The activity Bharat Bhushan Tuteja was appointed as a Managing Director was appointed as a Managing Director on 18 Mar 1996 & has been associated with this company since 29 years 8 months . was completed.
Dynor Pharmaceuticals Private Limited was registered on 18 Mar 1996 with Roc Delhi & aged 29 years 8 months as per MCA records. was recorded as a recent event.
The CIN of Dynor Pharmaceuticals Private Limited is U24231DL1996PTC077290.
Dynor Pharmaceuticals Private Limited is headquartered at 10/38 Geeta Colony, New Delhi, Delhi, 110031.
Dynor Pharmaceuticals Private Limited was incorporated on 18 March 1996.
The current directors of Dynor Pharmaceuticals Private Limited are
The primary industry of Dynor Pharmaceuticals Private Limited is Trade.
Dynor Pharmaceuticals Private Limited is unlisted.
The authorized capital of Dynor Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Dynor Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX